Clinical Trials Directory

Trials / Unknown

UnknownNCT02933398

A Trial Comparing - Robotic Assisted Versus Laparoscopic Partial Nephrectomy For Small Renal Masses

A Prospective Randomized Controlled Trial Comparing Two Minimally Invasive Surgical Modalities - Robotic Assisted Vs. Pure Laparoscopic Partial Nephrectomy For Small Renal Masses.

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
104 (estimated)
Sponsor
St. Joseph's Healthcare Hamilton · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A prospective, randomized, controlled trial including patients who are diagnosed with a small renal mass (\<4 cm) amenable to resection using either RALPN or LPN.

Detailed description

Small renal masses (SRM) \<4cm are increasingly being discovered incidentally on imaging. The standard of care for management of SRMs is partial nephrectomy whenever feasible. In the last 10 years, a minimally invasive laproscopic approach has largely supplanted open surgery for the treatment of SRMs. Robot-assisted laparoscopic partial nephrectomy (RALPN) has emerged as an alternative to laparoscopic partial nephrectomy (LPN) and has been able to bridge the technical difficulties of LPN. The big question about the role and cost of RALPN in comparison to LPN especially in Canadian healthcare for SRMs still remains unanswered. The objective of this proposed study is to conduct a randomized controlled trial to determine whether RALPN is better than LPN for the management of patients with SRMs. The primary outcomes will be warm ischemia time and secondary outcomes will be estimated glomerular filtration rate (eGFR), estimated blood loss, complication rate, length of hospital stay, positive surgical margin rate and cost comparison of these two techniques.

Conditions

Interventions

TypeNameDescription
PROCEDURERobotic Assisted NephrectomyRobotic (Davinci)
PROCEDURELaparoscopic Assisted NephrectomyRegular Laparoscopic Technique.

Timeline

Start date
2021-12-01
Primary completion
2022-12-01
Completion
2022-12-01
First posted
2016-10-14
Last updated
2021-03-19

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02933398. Inclusion in this directory is not an endorsement.